STOCK TITAN

Astrana Health (ASTH) Stock Price, News & Analysis

ASTH NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
27 252 sessions, October 30, 2025 to October 30, 2026
Largest daily move
+29.5% close of March 2, 2026
1-year change
+14.8% closing prices, October 30, 2025 to October 30, 2026
1-month change
+2.7% closing prices, September 30, 2026 to October 30, 2026

Company Description

Astrana Health, Inc. (NASDAQ: ASTH) is described as a physician-centric, AI-powered and technology-enabled healthcare company that supports providers in delivering high-quality, patient-centered care. According to the company’s public statements, Astrana is focused on making care more accessible, coordinated, and high-value by combining a scalable care delivery infrastructure, a proprietary technology platform, and aligned provider networks.

Astrana operates in the healthcare sector and is associated with the medical care facilities and population health management space. The company characterizes itself as patient-centered and physician-centric, with an emphasis on proactive, preventive care delivered at scale. Its model is built from the physician’s perspective, aiming to improve patient outcomes, enhance patient experiences, support provider well-being, and create greater value across the healthcare system.

Business model and segments

Based on available information, Astrana is an integrated population health management company. It focuses on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company reports three segments: Care Partners, Care Delivery, and Care Enablement. Astrana has stated that it generates the majority of its revenue from the Care Partners segment.

Through its affiliated provider networks, management services organization, and integrated care delivery clinics that span primary, specialty, and ancillary care, Astrana supports value-based care arrangements. Public disclosures note that Astrana supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements. Earlier company descriptions referenced support for more than 12,000 providers and over one million patients, indicating that Astrana has expanded the scale of its operations over time.

Technology platform and AI focus

Astrana describes its platform as both technology-enabled and AI-powered. The company highlights a proprietary, end-to-end technology platform that is designed to empower providers to deliver more proactive and preventive care. Astrana associates this platform with real-time visibility into patients’ health, longitudinal patient relationships, and value-based care operations. In its public communications, Astrana links its use of automation and AI to operational efficiency and to supporting clinical and care management capabilities.

Value-based care and population health

The company emphasizes value-based care arrangements as a core part of its business. Astrana states that it supports providers and patients in value-based arrangements across multiple lines of business, including Medicare Advantage, Medicaid, and Commercial products, particularly through its networks and acquired businesses. Its population health management approach is described as coordinated and outcomes-based, with a focus on controlling medical cost trends while maintaining or improving quality and outcomes.

According to company materials, Astrana’s affiliated networks and clinics span primary care, specialty care, and ancillary services. Within this framework, Astrana’s Care Partners, Care Delivery, and Care Enablement segments relate to provider networks, care delivery sites, and enabling services and technology that support value-based care and delegated risk models.

Prospect Health acquisition and expanded footprint

On July 1, 2025, Astrana completed the acquisition of Prospect Health, a value-based integrated care delivery network. Prospect Health has been described as coordinating the delivery of high-quality care through a network of over 11,000 providers across Southern California, Texas, Arizona, and Rhode Island in its medical groups. Prospect Health serves approximately 600,000 members across Medicare Advantage, Medicaid, and Commercial lines of business and operates a California Restricted Knox-Keene-licensed health plan, a management services organization, a specialty pharmacy, and an acute care hospital.

Astrana has stated that the acquisition of Prospect Health is intended to deepen its capabilities in providing access to high-quality and high-value care and to expand its scale, capabilities, and physician reach across key markets. Subsequent company communications refer to combined operations with Prospect Health and integration efforts that are intended to expand Astrana’s care delivery platform.

Provider networks and care delivery infrastructure

Across its operations, Astrana reports that it supports providers through affiliated provider networks and a management services organization. The company also references integrated care delivery clinics that cover primary, specialty, and ancillary care. These elements form a care delivery infrastructure that Astrana associates with coordinated care, value-based arrangements, and delegated models where it manages aspects of medical cost and care quality.

In addition to its own networks and clinics, Astrana has highlighted partnerships with other health systems and provider groups. For example, the company has publicly announced a strategic partnership with Intermountain Health to expand access to coordinated care in southern Nevada by integrating Astrana’s provider network and clinics with Intermountain’s health system capabilities. Astrana has also disclosed partnerships with provider groups in Southern California within its Care Enablement business.

Financial reporting and growth orientation

Astrana is a public company that files reports with the U.S. Securities and Exchange Commission and trades on NASDAQ under the symbol ASTH. The company issues quarterly earnings releases and related Form 8-K filings that describe its financial results, segment performance, and guidance. In these communications, Astrana frequently references revenue and adjusted EBITDA, as well as medical cost trends and performance across its Care Partners, Care Delivery, and Care Enablement segments.

Company statements link its financial performance to the scale of its provider and patient base, the effectiveness of its value-based care model, and integration of acquired entities such as Collaborative Health Systems and Prospect Health. Astrana also notes the use of a term loan credit facility in connection with the Prospect Health acquisition and has discussed net leverage targets in its public disclosures.

Corporate communications and investor engagement

Astrana regularly participates in healthcare and investor conferences, including events hosted by J.P. Morgan, Wells Fargo, Morgan Stanley, Baird, and William Blair. The company uses these events, along with conference calls and webcasts, to discuss its financial results, strategy, and operations. Astrana also furnishes investor presentations via Form 8-K and maintains an investor relations calendar where it posts webcast links and presentation materials.

Stock Performance

$36.48
-0.14%
-0.05
Last updated: November 2, 2026 at 11:32
+14.8%
Performance 1 year

Astrana Health (ASTH) closed at $36.53 on October 30, 2026. Over the past 12 months, the price has gained 14.8%.

See what a $1,000 investment in ASTH would be worth today

Average down calculator for ASTH

ASTH Metrics & Rankings

Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Financial Highlights

Astrana Health generated $3.2B in revenue in FY2025, retaining a 10.7% gross margin, operating income reached $78.5M (2.5% operating margin), and net income was $22.5M, reflecting a 0.7% net profit margin. Diluted earnings per share stood at $0.46. The company generated $114.6M in operating cash flow. The current ratio was 1.40, measuring current assets divided by current liabilities.

$3.2B
Revenue (FY2025)
$22.5M
Net Income (FY2025)
$114.6M
Operating Cash Flow

Upcoming Events

NOV
05
November 5, 2026 Earnings

Q3 2026 results

Q3 2026 financial results released after market close on Nov 5, 2026; covers quarter ended September 30, 2026; webcast likely.
NOV
05
November 5, 2026 Earnings

Earnings conference call

Conference call on Nov 5 at 2:30 p.m. PT / 5:30 p.m. ET; Astrana to host call with webcast and dial-in; details to be posted on site.

Astrana Health has 2 upcoming scheduled events. The next event, "Q3 2026 results", is scheduled for November 5, 2026 (in 3 days). All of them are earnings releases or calls. Investors can track these dates to stay informed about potential catalysts that may affect the ASTH stock price.

Short Interest History

Last 12 Months

Short interest in Astrana Health (ASTH) currently stands at 3.0 million shares, down 2.5% from the previous reporting period, representing 6.8% of the float. Since November 2025, short interest has increased by 26.3%.

Days to Cover History

Last 12 Months

Days to cover for Astrana Health (ASTH) currently stands at 8.8 days, up 52.6% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 173.1%. Across the settlements charted above, it has ranged from 3.1 to 11.7 days.

ASTH Company Profile & Sector Positioning

Astrana Health (ASTH) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the NASDAQ.

Investors comparing ASTH often look at related companies in the same sector, including AMN Healthcare Services (AMN), Sonida Senior Living, Inc. (SNDA), Ardent Health, Inc. (ARDT), Healthcare Services Group (HCSG), and The Pennant Group, Inc. (PNTG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ASTH's relative position within its industry.

Frequently Asked Questions

The current stock price of Astrana Health (ASTH) is $36.48 as of November 2, 2026.

The market cap of Astrana Health (ASTH) is approximately $1.8B. Learn more about what market capitalization means .

The FY2025 revenue of Astrana Health (ASTH) is $3.2B, from its most recent completed fiscal year.

The FY2025 net income of Astrana Health (ASTH) is $22.5M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Astrana Health (ASTH) is $0.46 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Astrana Health (ASTH) is $114.6M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Astrana Health (ASTH) is 0.7% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Astrana Health (ASTH) is 2.5% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Astrana Health (ASTH) is 10.7% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Astrana Health (ASTH), current assets divided by current liabilities, was 1.40 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Astrana Health (ASTH) is $341.5M for FY2025, its most recent completed fiscal year.

The operating income of Astrana Health (ASTH) is $78.5M for FY2025, its most recent completed fiscal year. Learn about operating income.

Astrana Health, Inc. is a physician-centric, AI-powered and technology-enabled healthcare company that focuses on delivering high-quality, patient-centered care. It operates in the healthcare sector and is associated with medical care facilities, population health management, and value-based care.

Astrana describes itself as a patient-centered, physician-centric integrated population health management company. It focuses on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions.

Astrana reports three main segments: Care Partners, Care Delivery, and Care Enablement. These segments reflect its provider networks, care delivery infrastructure, and enabling services and technology that support value-based care and population health management.

According to the company’s description, Astrana generates the majority of its revenue from the Care Partners segment, which is associated with its provider-centric activities and networks.

Astrana has stated that it supports more than 20,000 providers and over 1.6 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care.

Astrana characterizes itself as AI-powered and technology-enabled. It highlights a proprietary, end-to-end technology platform that supports proactive, preventive care, real-time visibility into patients’ health, and operational efficiency in value-based and delegated care models.

On July 1, 2025, Astrana completed the acquisition of Prospect Health, a value-based integrated care delivery network with over 11,000 providers and approximately 600,000 members across Medicare Advantage, Medicaid, and Commercial lines of business. Prospect Health also operates a California Restricted Knox-Keene-licensed health plan, a management services organization, a specialty pharmacy, and an acute care hospital. Astrana has stated that this acquisition expands its scale, capabilities, and physician reach.

Astrana reports that it operates through affiliated provider networks, a management services organization, and integrated care delivery clinics that span primary, specialty, and ancillary care. Through these settings, it supports value-based care and coordinated, outcomes-focused services.

Company disclosures indicate that Astrana supports value-based care arrangements across Medicare Advantage, Medicaid, and Commercial lines of business, including through its acquisition of Prospect Health and its affiliated provider networks.

Investors can review Astrana Health’s press releases, quarterly earnings announcements, and SEC filings such as Forms 10-K, 10-Q, and 8-K. The company also provides investor presentations and participates in healthcare and investor conferences, where it discusses financial results and strategy.